Mammalian ceramide synthases

IUBMB Life

Volumn 62, Issue 5, 2010, Pages 347-356

  Levy, Michal ^a   Futerman, Anthony H ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

Biosynthesis; Ceramide; Endoplasmic reticulum; Intracellular signaling; Metabolism; Sphingolipid

Indexed keywords

CARBOPLATIN; CERAMIDE; CERAMIDE SYNTHASE; CERAMIDE SYNTHASE 1; CERAMIDE SYNTHASE 2; CERAMIDE SYNTHASE 3; CERAMIDE SYNTHASE 4; CERAMIDE SYNTHASE 5; CERAMIDE SYNTHASE 6; CISPLATIN; DOXORUBICIN; GEMCITABINE; IMATINIB; SYNTHETASE; UNCLASSIFIED DRUG; VINCRISTINE;

ACYLATION; ALZHEIMER DISEASE; APOPTOSIS; CANCER INHIBITION; CARBOXY TERMINAL SEQUENCE; CATALYSIS; CELLULAR DISTRIBUTION; CHRONIC MYELOID LEUKEMIA; DEGENERATIVE DISEASE; DRUG SENSITIVITY; ENZYME ACTIVE SITE; ENZYME DEGRADATION; ENZYME REGULATION; HEAD AND NECK CARCINOMA; HUMAN; LEUKEMIA CELL; NONHUMAN; REVIEW; TISSUE DISTRIBUTION; TUMOR METASTASIS SUPPRESSOR GENE 1; TUMOR SUPPRESSOR GENE;

ANIMALS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; MEMBRANE PROTEINS; NEOPLASMS; SPHINGOSINE; SPHINGOSINE N-ACYLTRANSFERASE; TUMOR SUPPRESSOR PROTEINS;

MAMMALIA;

EID: 77953561361     PISSN: 15216543     EISSN: 15216551     Source Type: Journal    
DOI: 10.1002/iub.319     Document Type: Review

References (81)

1. Pettus, B. J., Chalfant, C. E., and Hannun, Y. A. (2002) Ceramide in apoptosis: an overview and current perspectives. Biochim. Biophys. Acta. 1585, 114-125.
2. Kolesnick, R. (2002) The therapeutic potential of modulating the ceramide/sphingomyelin pathway. J. Clin. Invest. 110, 3-8.
3. Futerman, A. H. and Riezman, H. (2005) The ins and outs of sphingolipid synthesis. Trends Cell. Biol. 15, 312-318.
4. Hanada, K. (2006) Discovery of the molecular machinery CERT for endoplasmic reticulum-to-Golgi trafficking of ceramide. Mol. Cell. Biochem. 286, 23-31.
5. Dolgachev, V., Farooqui, M. S., Kulaeva, O. I., Tainsky, M. A., Nagy, B., Hanada, K., and Separovic, D. (2004) De novo ceramide accumulation due to inhibition of its conversion to complex sphingolipids in apoptotic photosensitized cells. J. Biol. Chem. 279, 23238-23249.
6. Hanada, K., Kumagai, K., Yasuda, S., Miura, Y., Kawano, M., Fukasawa, M., and Nishijima, M. (2003) Molecular machinery for non-vesicular trafficking of ceramide. Nature 426, 803-809.
7. Pewzner-Jung, Y., Ben-Dor, S., and Futerman, A. H. (2006) When do Lasses (longevity assurance genes) become CerS (ceramide synthases)?: insights into the regulation of ceramide synthesis. J. Biol. Chem. 281, 25001-25005.
8. Venkataraman, K., Riebeling, C., Bodennec, J., Riezman, H., Allegood, J. C., Sullards, M. C., Merrill, A. H., Jr., and Futerman, A. H. (2002) Upstream of growth and differentiation factor 1 (uog1) , a mammalian homolog of the yeast longevity assurance gene 1 (LAG1) , regulates N-stearoyl-sphinganine (C18-(dihydro) ceramide) synthesis in a fumonisin B1-independent manner in mammalian cells. J. Biol. Chem. 277, 35642-35649.
9. Guillas, I., Jiang, J. C., Vionnet, C., Roubaty, C., Uldry, D., Chuard, R., Wang, J., Jazwinski, S. M., and Conzelmann, A. (2003) Human homo-logues of LAG1 reconstitute Acyl-CoA-dependent ceramide synthesis in yeast. J. Biol. Chem. 278, 37083-37091.
10. Riebeling, C., Allegood, J. C., Wang, E., Merrill, A. H., Jr., and Futerman, A. H. (2003) Two mammalian longevity assurance gene (LAG1) family members, trh1 and trh4, regulate dihydroceramide synthesis using different fatty acyl-CoA donors. J. Biol. Chem. 278, 43452-43459.
11. Laviad, E. L., Albee, L., Pankova-Kholmyansky, I., Epstein, S., Park, H., Merrill, A. H., Jr., and Futerman, A. H. (2008) Characterization of ceramide synthase 2: tissue distribution, substrate specificity, and inhibition by sphingosine 1-phosphate. J. Biol. Chem. 283, 5677-5684.
12. D'Mello N, P., Childress, A. M., Franklin, D. S., Kale, S. P., Pinswasdi, C., and Jazwinski, S. M. (1994) Cloning and characterization of LAG1, a longevity-assurance gene in yeast. J. Biol. Chem. 269, 15451-15459.
13. Jiang, J. C., Kirchman, P. A., Zagulski, M., Hunt, J., and Jazwinski, S. M. (1998) Homologs of the yeast longevity gene LAG1 in Caenorhabditis elegans and human. Genome. Res. 8, 1259-1272.
14. Barz, W. P. and Walter, P. (1999) Two endoplasmic reticulum (ER) membrane proteins that facilitate ER-to-Golgi transport of glycosylphos- phatidylinositol-anchored proteins. Mol. Biol. Cell. 10, 1043-1059.
15. Guillas, I., Kirchman, P. A., Chuard, R., Pfefferli, M., Jiang, J. C., Jazwinski, S. M., and Conzelmann, A. (2001) C26-CoA-dependent cer-amide synthesis of Saccharomyces cerevisiae is operated by Lag1p and Lac1p. EMBO J. 20, 2655-2665.
16. Lee, S. J. (1991) Expression of growth/differentiation factor 1 in the nervous system: conservation of a bicistronic structure. Proc. Natl. Acad. Sci. USA 88, 4250-4254.
17. Winter, E. and Ponting, C. P. (2002) TRAM, LAG1 and CLN8: members of a novel family of lipid-sensing domains?. Trends Biochem. Sci. 27, 381-383.
18. Venkataraman, K. and Futerman, A. H. (2002) Do longevity assurance genes containing Hox domains regulate cell development via ceramide synthesis? FEBS Lett. 528, 3-4.
19. Spassieva, S., Seo, J. G., Jiang, J. C., Bielawski, J., Alvarez-Vasquez, F., Jazwinski, S. M., Hannun, Y. A., and Obeid, L. M. (2006) Necessary role for the Lag1p motif in (dihydro) ceramide synthase activity. J. Biol. Chem. 281, 33931-33938.
20. Kageyama-Yahara, N. and Riezman, H. (2006) Transmembrane topology of ceramide synthase in yeast. Biochem. J. 398, 585-593.
21. Lahiri, S., Lee, H., Mesicek, J., Fuks, Z., Haimovitz-Friedman, A., Kolesnick, R. N., and Futerman, A. H. (2007) Kinetic characterization of mammalian ceramide synthases: determination of K(m) values towards sphinganine. FEBS Lett. 581, 5289-5294.
22. Lahiri, S., Park, H., Laviad, E. L., Lu, X., Bittman, R., and Futerman, A. H. (2009) Ceramide synthesis is modulated by the sphingosine analog FTY720 via a mixture of uncompetitive and noncompetitive inhibition in an acyl-CoA chain length-de pendent manner. J. Biol. Chem. 284, 16090-16098.
23. Mizutani, Y., Kihara, A., and Igarashi, Y. (2005) Mammalian Lassõ and its related family members regulate synthesis of specific ceramides. Biochem. J. 390, 263-271.
24. Gehring, W. J., Affolter, M., and Burglin, T. (1994) Homeodomain proteins. Annu. Rev. Biochem. 63, 487-526.
25. Mesika, A., Ben-Dor, S., Laviad, E. L., and Futerman, A. H. (2007) A new functional motif in Hox domain-containing ceramide synthases: identification of a novel region flanking the Hox and TLC domains essential for activity. J. Biol. Chem. 282, 27366-27373.
26. Mandon, E. C., Ehses, I., Rother, J., van Echten, G., and Sandhoff, K. (1992) Subcellular localization and membrane topology of serine palmitoyltransferase, 3-dehydrosphinganine reductase, and sphinganine N-acyltransferase in mouse liver. J. Biol. Chem. 267, 11144-11148.
27. Hirschberg, K., Rodger, J., and Futerman, A. H. (1993) The long-chain sphingoid base of sphingolipids is acylated at the cytosolic surface of the endoplasmic reticulum in rat liver. Biochem. J. 290 (Pt 3), 751-757.
28. Shimeno, H., Soeda, S., Sakamoto, M., Kouchi, T., Kowakame, T., and Kihara, T. (1998) Partial purification and characterization of sphingosine N-acyltransferase (ceramide synthase) from bovine liver mitochondrionrich fraction. Lipids 33, 601-605.
29. Siskind, L. J. (2005) Mitochondrial ceramide and the induction of apoptosis. J. Bioenerg. Biomembr. 37, 143-153.
30. Yu, J., Novgorodov, S. A., Chudakova, D., Zhu, H., Bielawska, A., Bielawski, J., Obeid, L. M., Kindy, M. S., and Gudz, T. I. (2007) JNK3 signaling pathway activates ceramide synthase leading to mitochondrial dysfunction. J. Biol. Chem. 282, 25940-25949.
31. Becker, K. P., Kitatani, K., Idkowiak-Baldys, J., Bielawski, J., and Hannun, Y. A. (2005) Selective inhibition of juxtanuclear translocation of protein kinase C betaII by a negative feedback mechanism involving ceramide formed from the salvage pathway. J. Biol. Chem. 280, 2606-2612.
32. Kitatani, K., Idkowiak-Baldys, J., Bielawski, J., Taha, T. A., Jenkins, R. W., Senkal, C. E., Ogretmen, B., Obeid, L. M., and Hannun, Y. A. (2006) Protein kinase C-induced activation of a ceramide/protein phos-phatase 1 pathway leading to dephosphorylation of p38 MAPK. J. Biol. Chem. 281, 36793-36802.
33. Villen, J., Beausoleil, S. A., Gerber, S. A., and Gygi, S. P. (2007) Large-scale phosphorylation analysis of mouse liver. Proc. Natl. Acad. Sci. USA 104, 1488-1493.
34. Vallee, B., and Riezman, H. (2005) Lip1p: a novel subunit of acyl-CoA ceramide synthase. EMBO J. 24, 730-741.
35. Lahiri, S. and Futerman, A. H. (2005) LASS5 is a bona fide dihydroceramide synthase that selectively utilizes palmitoyl-CoA as acyl donor. J. Biol. Chem. 280, 33735-33738.
36. Mizutani, Y., Kihara, A., and Igarashi, Y. (2006) LASS3 (longevity assurance homologue 3) is a mainly testis-specific (dihydro) ceramide synthase with relatively broad substrate specificity. Biochem. J. 398, 531-538.
37. Becker, I., Wang-Eckhardt, L., Yaghootfam, A., Gieselmann, V., and Eckhardt, M. (2008) Differential expression of (dihydro) ceramide synthases in mouse brain: oligodendrocyte-specific expression of CerS2/ Lass2. Histochem. Cell. Biol. 129, 233-241.
38. Schulz, A., Mousallem, T., Venkataramani, M., Persaud-Sawin, D. A., Zucker, A., Luberto, C., Bielawska, A., Bielawski, J., Holthuis, J. C., Jazwinski, S. M., Kozhaya, L., Dbaibo, G. S., and Boustany, R. M. (2006) The CLN9 protein, a regulator of dihydroceramide synthase. J. Biol. Chem. 281, 2784-2794.
39. Koybasi, S., Senkal, C. E., Sundararaj, K., Spassieva, S., Bielawski, J., Osta, W., Day, T. A., Jiang, J. C., Jazwinski, S. M., Hannun, Y. A., Obeid, L. M., and Ogretmen, B. (2004) Defects in cell growth regulation by C18:0-ceramide and longevity assurance gene 1 in human head and neck squamous cell carcinomas. J. Biol. Chem. 279, 44311-44319.
40. Saddoughi, S. A., Song, P., and Ogretmen, B. (2008) Roles of bioactive sphingolipids in cancer biology and therapeutics. Subcell. Biochem. 49, 413-440.
41. Karahatay, S., Thomas, K., Koybasi, S., Senkal, C. E., Elojeimy, S., Liu, X., Bielawski, J., Day, T. A., Gillespie, M. B., Sinha, D., Norris, J. S., Hannun, Y. A., and Ogretmen, B. (2007) Clinical relevance of cer-amide metabolism in the pathogenesis of human head and neck squamous cell carcinoma (HNSCC): attenuation of C(18) -ceramide in HNSCC tumors correlates with lymphovascular invasion and nodal metastasis. Cancer Lett. 256, 101-111.
42. Min, J., Mesika, A., Sivaguru, M., van Veldhoven, P. P., Alexander, H., Futerman, A. H., and Alexander, S. (2007) (Dihydro) ceramide synthase 1 regulated sensitivity to cisplatin is associated with the activation of p38 mitogen-activated protein kinase and is abrogated by sphingosine kinase 1. Mol. Cancer Res. 5, 801-812.
43. Senkal, C. E., Ponnusamy, S., Rossi, M. J., Bialewski, J., Sinha, D., Jiang, J. C., Jazwinski, S. M., Hannun, Y. A., and Ogretmen, B. (2007) Role of human longevity assurance gene 1 and C18-ceramide in chemotherapy-induced cell death in human head and neck squamous cell carcinomas. Mol. Cancer Ther. 6, 712-722.
44. Baran, Y., Salas, A., Senkal, C. E., Gunduz, U., Bielawski, J., Obeid, L. M., and Ogretmen, B. (2007) Alterations of ceramide/sphingosine 1-phosphate rheostat involved in the regulation of resistance to imatinib-induced apoptosis in K562 human chronic myeloid leukemia cells. J. Biol. Chem. 282, 10922-10934.
45. Sridevi, P., Alexander, H., Laviad, E. L., Pewzner-Jung, Y., Hannink, M., Futerman, A. H., and Alexander, S. (2009) Ceramide synthase 1 is regulated by proteasomal mediated turnover. Biochim. Biophys. Acta. 1793, 1218-1227.
46. Sridevi, P., Alexander, H., Laviad, E. L., Min, J., Mesika, A., Hannink, M., Futerman, A. H., and Alexender, S. (2010) Stress-induced ER to Golgi translocation of ceramide synthase 1 is dependent on proteasomal processing. Exp. Cell. Res. 316, 78-91.
47. Cai, X. F., Tao, Z., Yan, Z. Q., Yang, S. L., and Gong, Y. (2003) Molecular cloning, characterisation and tissue-specific expression of human LAG3, a member of the novel Lag1 protein family. DNA Seq. 14, 79-86.
48. He, X. H., Tan, W. X., Wang, J. R., Hu, J., Zhu, H. X., Wan, D. F., and Gu, J. R. (2002) [Chromosome localization and genomic organization of five novel human genes related to cell growth control]. Yi Chuan 24, 111-116.
49. Pan, H., Qin, W. X., Huo, K. K., Wan, D. F., Yu, Y., Xu, Z. G., Hu, Q. D., Gu, K. T., Zhou, X. M., Jiang, H. Q., Zhang, P. P., Huang, Y., Li, Y. Y., and Gu, J. R. (2001) Cloning, mapping, and characterization of a human homologue of the yeast longevity assurance gene. LAG1 Genomics. 77, 58-64.
50. Farkash-Amar, S., Lipson, D., Polten, A., Goren, A., Helmstetter, C., Yakhini, Z., and Simon, I. (2008) Global organization of replication time zones of the mouse genome. Genome. Res. 18, 1562-1570.
51. Ma, C., Ning, J., You, J., Liu, L., Wang, J., Cui, X., Wu, B., and Zheng, J. (2003) Primary functional identification of gene TMSG-1. Sci. China C Life Sci. 46, 641-650.
52. Yu, Y., Lu, H., Pan, H., Ma, J. H., Ding, Z. J., and Li, Y. Y. (2006) Expression of LASS2 controlled by LAG1 or ADH1 promoters cannot functionally complement Lag1p. Microbiol. Res. 161, 203-211.
53. Mandala, S. M., Thornton, R., Tu, Z., Kurtz, M. B., Nickels, J., Broach, J., Menzeleev, R., and Spiegel, S. (1998) Sphingoid base 1-phosphate phosphatase: a key regulator of sphingolipid metabolism and stress response. Proc. Natl. Acad. Sci. USA 95, 150-155.
54. Spassieva, S. D., Mullen, T. D., Townsend, D. M., and Obeid, L. M. (2009) Disruption of ceramide synthesis by CerS2 down-regulation leads to autophagy and the unfolded protein response. Biochem. J. 242, 273-283.
55. Schiffmann, S., Sandner, J., Birod, K., Wobst, I., Angioni, C., Ruckhaberle, E., Kaufmann, M., Ackermann, H., Lotsch, J., Schmidt, H., Geisslinger, G., and Grosch, S. (2009) Ceramide synthases and ceramide levels are increased in breast cancer tissue. Carcinogenesis 30, 745-752.
56. Erez-Roman, R., Pienik, R., and Futerman, A. H. (2010) Increased ceramide synthase 2 and 6 mRNA levels in breast cancer tissues and correlation with sphingosine kinase expression. Biochem. Biophys. Res. Commun. 391, 219-223.
57. Bonzon-Kulichenko, E., Schwudke, D., Gallardo, N., Molto, E., Fernandez-Agullo, T., Shevchenko, A., and Andres, A. (2009) Central leptin regulates total ceramide content and sterol regulatory element binding protein-1C proteolytic maturation in rat white adipose tissue. Endocrinology 150, 169-178.
58. Wang, X., Carre, W., Saxton, A. M., and Cogburn, L. A. (2007) Manipulation of thyroid status and/or GH injection alters hepatic gene expression in the juvenile chicken. Cytogenet. Genome. Res. 117, 174-188.
59. Harvey, S. (1983) Thyroid hormones inhibit growth hormone secretion in domestic fowl (Gallus domesticus). J. Endocrinol. 96, 329-334.
60. Pewzner-Jung, Y., Park, H., Laviad, E. L., Silva, L. C., Lahiri, S., Stiban, J., Erez-Roman, R., Brugger, B., Sachsenheimer, T., Wieland, F. T., Prieto, M., Merrill, A. H., and Futerman, A. H. (2010) A critical role for ceramide synthase 2 in liver homeostasis. I. Alterations in lipid metabolic pathways. J. Biol. Chem.; 10.1074/jbc.M1109.077594
61. Pewzner-Jung, Y., Brenner, O., Braunn, S., Laviad, E. L., Ben -Dor, S., Feldmesser, E., Horn-Saban, S., Amann-Zalcenstein, D., Raanan, C., Berkutzki, T., Erez-Roman, R., Ben-David, O., Levy, M., Holzman, D., Park, H., Nyska, A., Merrill, A. H., and Futerman, A. H. (2010) A critical role for ceramide synthase 2 in liver homeostasis. II. Insights into molecular changes leading to hepatopathy. J. Biol. Chem.; 10.1074/ jbc.M1109.077610.
62. Imgrund, S., Hartmann, D., Farwanah, H., Eckhardt, M., Sandhoff, R., Degen, J., Gieselmann, V., Sandhoff, K., and Willecke, K. (2009) Adult Ceramide Synthase 2 (Cers2) deficient mice exhibit myelin sheath defects, cerebellar degeneration and hepatocarcinomas. J. Biol. Chem. 284, 33549-33560.
63. Rabionet, M., van der Spoel, A. C., Chuang, C. C., von TumplingRadosta, B., Litjens, M., Bouwmeester, D., Hellbusch, C. C., Korner, C., Wiegandt, H., Gorgas, K., Platt, F. M., Grone, H. J., and Sandhoff, R. (2008) Male germ cells require polyenoic sphingolipids with complex glycosylation for completion of meiosis: a link to ceramide syn-thase-3. J. Biol. Chem. 283, 13357-13369.
64. Mizutani, Y., Kihara, A., Chiba, H., Tojo, H., and Igarashi, Y. (2008) 2-Hydroxy-ceramide synthesis by ceramide synthase family: enzymatic basis for the preference of FA chain length. J. Lipid. Res. 49, 2356-2364.
65. Han, X. and Cheng, H. (2005) Characterization and direct quantitation of cerebroside molecular species from lipid extracts by shotgun lipidomics. J. Lipid. Res. 46, 163-175.
66. Ponec, M., Weerheim, A., Kempenaar, J., Mulder, A., Gooris, G. S., Bouwstra, J., and Mommaas, A. M. (1997) The formation of competent barrier lipids in reconstructed human epidermis requires the presence of vitamin C. J. Invest. Dermatol. 109, 348-355.
67. Coderch, L., Lopez, O., De La Maza, A., and Parra, J. L. (2003) Ceramides and skin function. Am. J. Clin. Dermatol. 4, 107-129.
68. Wang, G., Silva, J., Dasgupta, S., and Bieberich, E. (2008) Long-chain ceramide is elevated in presenilin 1 (PS1M146V) mouse brain and induces apoptosis in PS1 astrocytes. Glia 56, 449-456.
69. Cutler, R. G., Kelly, J., Storie, K., Pedersen, W. A., Tammara, A., Hatanpaa, K., Troncoso, J. C., and Mattson, M. P. (2004) Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease. Proc. Natl. Acad. Sci. USA 101, 2070-2075.
70. Schorling, S., Vallee, B., Barz, W. P., Riezman, H., and Oesterhelt, D. (2001) Lag1p and Lac1p are essential for the Acyl-CoA-dependent ceramide synthase reaction in Saccharomyces cerevisae. Mol. Biol. Cell. 12, 3417-3427.
71. Cerantola, V., Vionnet, C., Aebischer, O. F., Jenny, T., Knudsen, J., and Conzelmann, A. (2007) Yeast sphingolipids do not need to contain very long chain fatty acids. Biochem. J. 401, 205-216.
72. Xu, Z., Zhou, J., Mccoy, D. M., and Mallampalli, R. K. (2005) LASS5 is the predominant ceramide synthase isoform involved in de novo sphingolipid synthesis in lung epithelia. J. Lipid. Res. 46, 1229-1238.
73. Jin, J., Hou, Q., Mullen, T. D., Zeidan, Y. H., Bielawski, J., Kraveka, J. M., Bielawska, A., Obeid, L. M., Hannun, Y. A., and Hsu, Y. T. (2008) Ceramide generated by sphingomyelin hydrolysis and the salvage pathway is involved in hypoxia/reoxygenation-induced Bax redistribution to mitochondria in NT-2 cells. J. Biol. Chem. 283, 26509-26517.
74. van Hall, T., Wolpert, E. Z., van Veelen, P., Laban, S., van Der Veer, M., Roseboom, M., Bres, S., Grufman, P., De Ru, A., Meiring, H., De Jong, A., Franken, K., Teixeira, A., Valentijn, R., Drijfhout, J. W., Koning, F., Camps, M., Ossendorp, F., Karre, K., Ljunggren, H. G., Melief, C. J., and Offringa, R. (2006) Selective cytotoxic T-lymphocyte targeting of tumor immune escape variants. Nat. Med. 12, 417-424.
75. Panjarian, S., Kozhaya, L., Arayssi, S., Yehia, M., Bielawski, J., Bielawska, A., Usta, J., Hannun, Y. A., Obeid, L. M., and Dbaibo, G. S. (2008) De novo N-palmitoylsphingosine synthesis is the major biochemical mechanism of ceramide accumulation following p53 up-regulation Prostaglandins Other. Lipid. Mediat. 86, 41-48.
76. Weinmann, A., Galle, P. R., and Teufel, A. (2005) LASS6, an additional member of the longevity assurance gene family. Int. J. Mol. Med. 16, 905-910.
77. Ruckhaberle, E., Rody, A., Engels, K., Gaetje, R., Von Minckwitz, G., Schiffmann, S., Grosch, S., Geisslinger, G., Holtrich, U., Karn, T., and Kaufmann, M. (2008) Microarray analysis of altered sphingolipid metabolism reveals prognostic significance of sphingosine kinase 1 in breast cancer. Breast. Cancer Res. Treat. 112, 41-52.
78. Walker, T., Mitchell, C., Park, M. A., Yacoub, A., Graf, M., Rahmani, M., Houghton, P. J., Voelkel-Johnson, C., Grant, S., and Dent, P. (2009) Sorafenib and vorinostat kill colon cancer cells by CD95-dependent and -independent mechanisms. Mol. Pharmacol. 76, 342-355.
79. White-Gilbertson, S., Mullen, T., Senkal, C., Lu, P., Ogretmen, B., Obeid, L., and Voelkel-Johnson, C. (2009) Ceramide synthase 6 modulates TRAIL sensitivity and nuclear translocation of active caspase-3 in colon cancer cells. Oncogene 28, 1132-1141.
80. Senkal, C. E., Ponnusamy, S., Bielawski, J., Hannun, Y. A., and Ogretmen, B. (2010) Antiapoptotic roles of ceramide-synthase-6-generated C16-ceramide via selective regulation of the ATF6/CHOP arm of ER-stress-response pathways. FASEB J. 24, 296-308.
81. Gustafsson, K., Sander, B., Bielawski, J., Hannun, Y. A., and Flygare, J. (2009) Potentiation of cannabinoid-induced cytotoxicity in mantle cell lymphoma through modulation of ceramide metabolism. Mol. Cancer Res. 7, 1086-1098.